BACK TO ALL REFERENCES
NanoPilot: Piloting nano-pharma production
NanoPilot sets up a flexible and adaptable pilot plant operating under GMP for the production of small batches of polymer-based nanopharmaceuticals.
€6.3 m
in funding
4
years
9
partners
Key numbers
About the project
NanoPilot will set up a flexible and adaptable pilot plant operating under GMP for the production of small batches of polymer-based nanopharmaceuticals, which exhibit significant potential in the field of drug-delivery particularly for the design of second-generation nanopharmaceuticals. The project partners aim to establish a pilot plant enabling high-quality custom manufacturing of early-stage clinical batches of sterile nano-pharmaceuticals.
Impact of the project:
The objective of this four-year long project is to build a pilot plant operating under Good Manufacturing Practice (GMP) for the production of polymer-based nanopharmaceuticals, accelerating the development of nanomedicine, currently in its infancy within the pharmaceutical sector.
Funding instrument Horizon 2020 SME instrument phase 2
Spinverse’s role
Spinverse assisted Cidetec, an RK4 Research Alliance technology centre in Spain, in its project proposal and business plan for NanoPilot and participates in the project as a partner during its active phase.
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
